Turning Stock Analysis

TPTX -  USA Stock  

USD 35.91  0.02  0.06%

Turning Point price slide over the last few months created some momentum for investors as it was traded today as low as 35.19 and as high as 37.85 per share. The company management teams were not very successful in positioning the company resources to exploit market volatility in December. However, diversifying your holdings with Turning Point Therapeutics or similar stocks can still protect your portfolio during high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 4.78. This high volatility is attributed to the latest market swings and not so good earnings reports for some of the Turning Point Therap partners.
Additionally, take a look at World Market Map.

Turning Stock Analysis 

 
Refresh
The Turning Point stock analysis report makes it easy to digest most publicly released information about Turning Point and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Turning Stock analysis module also helps to analyze the Turning Point price relationship with some important fundamental indicators such as market cap and management efficiency.

Turning Stock Analysis Notes

About 98.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.75. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Turning Point Therap recorded a loss per share of 4.23. The entity had not issued any dividends in recent years. Turning Point Therapeutics, Inc., a clinical-stage precision oncology biopharmaceutical company, engages in designing and developing therapies that target genetic drivers of cancer. The company was founded in 2013 and is headquartered in San Diego, California. Turning Point operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 237 people. To find out more about Turning Point Therapeutics contact the company at 858 926 5251 or learn more at https://www.tptherapeutics.com.

Turning Point Therap Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Turning Point's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Turning Point Therapeutics or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Turning Point Therap generated a negative expected return over the last 90 days
Turning Point Therap has high historical volatility and very poor performance
Turning Point Therap has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 30.83 M. Net Loss for the year was (205.48 M) with profit before overhead, payroll, taxes, and interest of 25 M.
Turning Point Therapeutics currently holds about 1.04 B in cash with (133.18 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 20.94.
Over 98.0% of the company shares are owned by institutional investors
Latest headline from www.marketbeat.com: Turning Point Therapeutics Upgraded by Zacks Investment Research to Hold - MarketBeat

Turning Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Turning Point is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Turning Point Therapeutics backward and forwards among themselves. Turning Point's institutional investor refers to the entity that pools money to purchase Turning Point's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Stonnington Group LlcCommon Shares5.1 K216 K
Vanguard Group IncCommon Shares3.9 M256.9 M
Blackrock IncCommon Shares3.8 M249.2 M
Wellington Management Group LlpCommon Shares3.4 M226.4 M
Price T Rowe Associates IncCommon Shares3.3 M218.3 M
Cormorant Asset Management LpCommon Shares2.8 M188.8 M
Orbimed Advisors LlcCommon Shares2.4 M156.9 M
Note, although Turning Point's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Turning Market Capitalization

The company currently falls under 'Mid-Cap' category with current market capitalization of 1.78 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Turning Point's market, we take the total number of its shares issued and multiply it by Turning Point's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Management Efficiency

The entity has return on total asset (ROA) of (14.14) % which means that it has lost $14.14 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (23.91) %, meaning that it created substantial loss on money invested by shareholders. Turning Point management efficiency ratios could be used to measure how well turning point therap manages its routine affairs as well as how well it operates its assets and liabilities.

Technical Drivers

As of the 23rd of January, Turning Point has the risk adjusted performance of (0.039288), and Coefficient Of Variation of (1,743). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Turning Point Therap, as well as the relationship between them. In other words, you can use this information to find out if the company will indeed mirror its model of past prices and volume data, or the prices will eventually revert. We were able to interpolate and analyze data for nineteen technical drivers for Turning Point Therapeutics, which can be compared to its competition. Please validate Turning Point Therap maximum drawdown, as well as the relationship between the downside variance and skewness to decide if Turning Point is priced more or less accurately, providing market reflects its prevalent price of 35.91 per share. Given that Turning Point Therap has jensen alpha of (0.20), we advise you to double-check Turning Point Therapeutics's current market performance to make sure the company can sustain itself at a future point.

Turning Point Therap Price Movement Analysis

Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Exponential Moving Average is calculated by weighting recent values of Turning Point Therap more heavily than older values. View also all equity analysis or get more info about exponential moving average overlap studies indicator.

Turning Point Therap Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Turning Point insiders, such as employees or executives, is commonly permitted as long as it does not rely on Turning Point's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Turning Point insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
North Annette over three months ago via Macroaxis 
Exercise or conversion by North Annette of 10000 shares of Turning Point subject to Rule 16b-3
Tombesi Paolo over three months ago via Macroaxis 
Acquisition by Tombesi Paolo of 61200 shares of Turning Point subject to Rule 16b-3
Partridge Andrew John over six months ago via Macroaxis 
Sale by Partridge Andrew John of 1869 shares of Turning Point
Alles Mark J over six months ago via Macroaxis 
Purchase by Alles Mark J of 2000 shares of Turning Point
North Annette over six months ago via Macroaxis 
Exercise or conversion by North Annette of 15000 shares of Turning Point subject to Rule 16b-3
Nicholson Garry A over six months ago via Macroaxis 
Acquisition by Nicholson Garry A of 8500 shares of Turning Point subject to Rule 16b-3
Alles Mark J over six months ago via Macroaxis 
Acquisition by Alles Mark J of 17000 shares of Turning Point subject to Rule 16b-3
North Annette over six months ago via Macroaxis 
Exercise or conversion by North Annette of 5882 shares of Turning Point subject to Rule 16b-3
Baker Brian Lee over six months ago via Macroaxis 
Exercise or conversion by Baker Brian Lee of 10688 shares of Turning Point subject to Rule 16b-3
North Annette over six months ago via Macroaxis 
Exercise or conversion by North Annette of 20000 shares of Turning Point subject to Rule 16b-3
Reich Siegfried over six months ago via Macroaxis 
Exercise or conversion by Reich Siegfried of 35550 shares of Turning Point subject to Rule 16b-3
Countouriotis Athena over six months ago via Macroaxis 
Exercise or conversion by Countouriotis Athena of 8942 shares of Turning Point subject to Rule 16b-3

Turning Point Predictive Daily Indicators

Turning Point intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Turning Point stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Turning Point Forecast Models

Turning Point time-series forecasting models is one of many Turning Point's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Turning Point's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Turning Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Turning Point stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Turning shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Turning Point. By using and applying Turning Stock analysis, traders can create a robust methodology for identifying Turning entry and exit points for their positions.
Turning Point Therapeutics, Inc., a clinical-stage precision oncology biopharmaceutical company, engages in designing and developing therapies that target genetic drivers of cancer. The company was founded in 2013 and is headquartered in San Diego, California. Turning Point operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 237 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Turning Point to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Bollinger Bands Now

   

Bollinger Bands

Use Bollinger Bands indicator to analyze target price for a given investing horizon
All  Next Launch Module
Additionally, take a look at World Market Map. Note that the Turning Point Therap information on this page should be used as a complementary analysis to other Turning Point's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Complementary Tools for Turning Stock analysis

When running Turning Point Therap price analysis, check to measure Turning Point's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Turning Point is operating at the current time. Most of Turning Point's value examination focuses on studying past and present price action to predict the probability of Turning Point's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Turning Point's price. Additionally, you may evaluate how the addition of Turning Point to your portfolios can decrease your overall portfolio volatility.
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Is Turning Point's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Turning Point. If investors know Turning will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Turning Point listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Turning Point Therap is measured differently than its book value, which is the value of Turning that is recorded on the company's balance sheet. Investors also form their own opinion of Turning Point's value that differs from its market value or its book value, called intrinsic value, which is Turning Point's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Turning Point's market value can be influenced by many factors that don't directly affect Turning Point's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Turning Point's value and its price as these two are different measures arrived at by different means. Investors typically determine Turning Point value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Turning Point's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.